These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10982631)

  • 1. GM-CSF gene therapy using adenoviral vector in hamster pancreatic cancer.
    Ogawa T; Kusumoto M; Mizumoto K; Sato N; Nagai E; Ikubo A; Aoki Y; Tanaka M
    J Hepatobiliary Pancreat Surg; 2000; 7(3):306-11. PubMed ID: 10982631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irradiated tumor cells adenovirally engineered to secrete granulocyte/macrophage-colony-stimulating factor establish antitumor immunity and eliminate pre-existing tumors in syngeneic mice.
    Nagai E; Ogawa T; Kielian T; Ikubo A; Suzuki T
    Cancer Immunol Immunother; 1998 Oct; 47(2):72-80. PubMed ID: 9769115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoviral GM-CSF Gene Transduction into Breast Cancer Cells Induced Long-Lasting Antitumor Immunity in Mice.
    Ogawa T; Kusumoto M; Mizumoto K; Sato N; Tanaka M
    Breast Cancer; 1999 Oct; 6(4):301-304. PubMed ID: 11091734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells.
    Yu JS; Burwick JA; Dranoff G; Breakefield XO
    Hum Gene Ther; 1997 Jun; 8(9):1065-72. PubMed ID: 9189764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effect induced by granulocyte/macrophage-colony-stimulating factor gene-modified tumor vaccination: comparison of adenovirus- and retrovirus-mediated genetic transduction.
    Abe J; Wakimoto H; Yoshida Y; Aoyagi M; Hirakawa K; Hamada H
    J Cancer Res Clin Oncol; 1995; 121(9-10):587-92. PubMed ID: 7559742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic immunotherapy of established tumors with adenovirus-murine granulocyte-macrophage colony-stimulating factor.
    Lee CT; Wu S; Ciernik IF; Chen H; Nadaf-Rahrov S; Gabrilovich D; Carbone DP
    Hum Gene Ther; 1997 Jan; 8(2):187-93. PubMed ID: 9017422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma.
    Soiffer R; Hodi FS; Haluska F; Jung K; Gillessen S; Singer S; Tanabe K; Duda R; Mentzer S; Jaklitsch M; Bueno R; Clift S; Hardy S; Neuberg D; Mulligan R; Webb I; Mihm M; Dranoff G
    J Clin Oncol; 2003 Sep; 21(17):3343-50. PubMed ID: 12947071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte-macrophage colony-stimulating factor and B7-2 combination immunogene therapy in an allogeneic Hu-PBL-SCID/beige mouse-human glioblastoma multiforme model.
    Parney IF; Petruk KC; Zhang C; Farr-Jones M; Sykes DB; Chang LJ
    Hum Gene Ther; 1997 Jun; 8(9):1073-85. PubMed ID: 9189765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective immunization against neuroblastoma using double-transduced tumor cells secreting GM-CSF and interferon-gamma.
    Bausero MA; Panoskaltsis-Mortari A; Blazar BR; Katsanis E
    J Immunother Emphasis Tumor Immunol; 1996 Mar; 19(2):113-24. PubMed ID: 8732694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Bicistronic Adenoviral Vector Carrying Cytosine Deaminase and Granulocyte-Macrophage Colony-Stimulating Factor Increases the Therapeutic Efficacy of Cancer Gene Therapy.
    Akbulut H; Coleri A; Sahin G; Tang Y; Icli F
    Hum Gene Ther; 2019 Aug; 30(8):999-1007. PubMed ID: 30892086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase 1 clinical trial of irradiated autologous melanoma cells adenovirally transduced with human GM-CSF gene.
    Kusumoto M; Umeda S; Ikubo A; Aoki Y; Tawfik O; Oben R; Williamson S; Jewell W; Suzuki T
    Cancer Immunol Immunother; 2001 Sep; 50(7):373-81. PubMed ID: 11676397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evaluation of herpes simplex virus armed with granulocyte-macrophage colony-stimulating factor in pancreatic carcinoma.
    Liu H; Yuan SJ; Chen YT; Xie YB; Cui L; Yang WZ; Yang DX; Tian YT
    World J Gastroenterol; 2013 Aug; 19(31):5138-43. PubMed ID: 23964149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental glioma.
    Herrlinger U; Jacobs A; Quinones A; Woiciechowsky C; Sena-Esteves M; Rainov NG; Fraefel C; Breakefield XO
    Hum Gene Ther; 2000 Jul; 11(10):1429-38. PubMed ID: 10910140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Oncolytic Adenovirus Encoding Decorin and Granulocyte Macrophage Colony Stimulating Factor Inhibits Tumor Growth in a Colorectal Tumor Model by Targeting Pro-Tumorigenic Signals and via Immune Activation.
    Liu Z; Yang Y; Zhang X; Wang H; Xu W; Wang H; Xiao F; Bai Z; Yao H; Ma X; Jin L; Wu C; Seth P; Zhang Z; Wang L
    Hum Gene Ther; 2017 Aug; 28(8):667-680. PubMed ID: 28530155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically engineered tumor cell vaccine in a head and neck cancer model.
    Couch M; Saunders JK; O'Malley BW; Pardoll D; Jaffee E
    Laryngoscope; 2003 Mar; 113(3):552-6. PubMed ID: 12616213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine therapy with gene-transfected cells: single injection of irradiated granulocyte-macrophage colony-stimulating factor-transduced cells accelerates hematopoietic recovery after cytotoxic chemotherapy in mice.
    Rosenthal FM; Früh R; Henschler R; Veelken H; Kulmburg P; Mackensen A; Gansbacher B; Mertelsmann R; Lindemann A
    Blood; 1994 Nov; 84(9):2960-5. PubMed ID: 7949168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human autologous in vitro models of glioma immunogene therapy using B7-2, GM-CSF, and IL12.
    Parney IF; Farr-Jones MA; Kane K; Chang LJ; Petruk KC
    Can J Neurol Sci; 2002 Aug; 29(3):267-75. PubMed ID: 12195617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adjuvant GM-CSF cytokine gene therapy for breast cancer].
    Ogawa T; Kusumoto M; Kuroki S; Nagata S; Yamanaka N; Kawano R; Yoshida J; Shinohara M; Matsuo K
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1512-4. PubMed ID: 11707967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinoma.
    Jaffee EM; Abrams R; Cameron J; Donehower R; Duerr M; Gossett J; Greten TF; Grochow L; Hruban R; Kern S; Lillemoe KD; O'Reilly S; Pardoll D; Pitt HA; Sauter P; Weber C; Yeo C
    Hum Gene Ther; 1998 Sep; 9(13):1951-71. PubMed ID: 9741433
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaccination for experimental gliomas using GM-CSF-transduced glioma cells.
    Herrlinger U; Kramm CM; Johnston KM; Louis DN; Finkelstein D; Reznikoff G; Dranoff G; Breakefield XO; Yu JS
    Cancer Gene Ther; 1997; 4(6):345-52. PubMed ID: 9408604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.